Curanex Pharmaceuticals Inc
CURX
$0.44
$0.037.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 677.50K | -- | -- | -- | -- |
| Gross Profit | -677.50K | -- | -- | -- | -- |
| SG&A Expenses | 533.00K | 352.40K | 338.90K | 281.60K | 230.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.21M | 352.40K | 338.90K | 281.60K | 230.40K |
| Operating Income | -1.21M | -352.40K | -338.90K | -281.60K | -230.40K |
| Income Before Tax | -1.29M | -426.30K | -410.20K | -352.80K | -228.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.29 | -0.43 | -0.41 | -0.35 | -0.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.29M | -426.30K | -410.20K | -352.80K | -228.30K |
| EBIT | -1.21M | -352.40K | -338.90K | -281.60K | -230.40K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.05 | -0.05 | -0.07 | -0.20 | -0.21 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.04 | -0.12 | -0.13 |
| EPS Diluted | -0.05 | -0.05 | -0.07 | -0.20 | -0.21 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.04 | -0.12 | -0.13 |
| Average Basic Shares Outstanding | 97.68M | 74.48M | 52.88M | 29.48M | 6.00M |
| Average Diluted Shares Outstanding | 97.68M | 74.48M | 52.88M | 29.48M | 6.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |